Acumen Pharmaceuticals, Inc.

ABOS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$35,627$66,886$130,101$122,162
Short-Term Investments$135,930$176,636$47,504$72,075
Receivables$0$225$0$0
Inventory$159$0$199$0
Other Curr. Assets$6,590$2,868$2,525$4,424
Total Curr. Assets$178,306$246,615$180,329$198,661
Property Plant & Equip (Net)$339$503$270$36
Goodwill$0$0$0$0
Intangibles$0$169$0$0
Long-Term Investments$59,968$62,553$15,837$31,619
Tax Assets$0$0$0$0
Other NC Assets$379$285$151$14
Total NC Assets$60,686$63,510$16,258$31,669
Other Assets$0$0$0$0
Total Assets$238,992$310,125$196,587$230,330
Liabilities
Payables$5,648$1,379$1,640$1,088
Short-Term Debt$133$866$105$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$21,826$10,726$6,067$4,059
Total Curr. Liab.$27,607$12,971$7,812$5,147
LT Debt$29,569$27,621$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$2,560$0$0
Total NC Liab.$29,569$30,181$0$0
Other Liabilities$0$0$0$0
Cap. Leases$283$1,150$105$0
Total Liabilities$57,176$43,152$7,812$5,147
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$4$4
Retained Earnings-$325,127-$222,798-$170,427-$127,571
AOCI-$48$312-$751-$231
Other Equity$506,985$489,453$359,949$352,981
Total Equity$181,816$266,973$188,775$225,183
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$238,992$310,125$196,587$230,330
Net Debt-$5,925-$38,399-$129,996-$122,162